6
Oct
2026

Biocon Limited

Exhibitor at CPHI Milan 2026 stand 7D34, Integrated Pharma
About Us

Biocon is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as Generic Formulations in the U.S., Europe & key emerging markets. It also has a pipeline of promising novel assets in immunotherapy under development.

Website: www.biocon.com; Follow-us on Twitter: @bioconlimited for company updates.




Biocon Biologics, a subsidiary of Biocon...

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    5000+
Company types
Biopharmaceutical company
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
  • Biocon Limited, , 20th KM, Hosur Road, Electronics City, 560100 , Bangelore, Karnataka, India
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 7D34, Integrated Pharma

Products Featured at CPHI Milan 2026

  • ACTIBLOK AM

    Product ACTIBLOK AM

    Biocon offers a wide range of metabolic which includes actiblok am. Composition: metoprolol succinate 25/50 mg and amlodipine 5 mg tablets. Mechanism of action: metoprolol is a beta1-selective (cardioselective) adrenergic receptor blocking agent, amlodipine: amlodipine is a dihydropyridine calcium channel ...